Clinical trials
Triple Negative Breast Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
639 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 10 |
| 2010 | 21 |
| 2011 | 16 |
| 2012 | 14 |
| 2013 | 14 |
| 2014 | 18 |
| 2015 | 36 |
| 2016 | 36 |
| 2017 | 62 |
| 2018 | 48 |
| 2019 | 54 |
| 2020 | 42 |
| 2021 | 49 |
| 2022 | 45 |
| 2023 | 34 |
| 2024 | 44 |
| 2025 | 47 |
| 2026 | 37 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 212 |
| Recruiting | 148 |
| Terminated | 122 |
| Active, not recruiting | 94 |
| Withdrawn | 20 |
| Unknown status | 19 |
| Not yet recruiting | 13 |
| Suspended | 7 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 40 |
| M.D. Anderson Cancer Center | 27 |
| Novartis Pharmaceuticals | 18 |
| City of Hope Medical Center | 11 |
| Pfizer | 11 |
| AstraZeneca | 10 |
| Memorial Sloan Kettering Cancer Center | 10 |
| Merck Sharp & Dohme LLC | 10 |
| AbbVie | 9 |
| H. Lee Moffitt Cancer Center and Research Institute | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 639 |
| Breast Neoplasms | 286 |
| Carcinoma, Non-Small-Cell Lung | 162 |
| Ovarian Neoplasms | 108 |
| Squamous Cell Carcinoma of Head and Neck | 84 |
| Melanoma | 71 |
| Colorectal Neoplasms | 69 |
| Carcinoma, Renal Cell | 68 |
| Neoplasm Metastasis | 67 |
| Endometrial Neoplasms | 63 |
Trials
Showing 26 to 50 of 639. Each trial links to its page on Pharma Observatory.
539 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.